SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-033141
Filing Date
2024-03-19
Accepted
2024-03-19 06:30:07
Documents
16
Period of Report
2024-03-19

Document Format Files

Seq Description Document Type Size
1 6-K ocs_6-k_erifrssfscomp_20.htm 6-K 27357
2 EX-99.1 ocs-ex99_1.htm EX-99.1 52184
3 EX-99.2 ocs-ex99_2.htm EX-99.2 2467378
4 EX-99.3 ocs-ex99_3.htm EX-99.3 461496
5 EX-99.4 ocs-ex99_4.htm EX-99.4 271843
6 GRAPHIC img187686630_0.jpg GRAPHIC 8129
7 GRAPHIC img187686630_1.jpg GRAPHIC 75864
8 GRAPHIC img187686630_2.jpg GRAPHIC 60938
9 GRAPHIC img187686630_3.jpg GRAPHIC 60110
10 GRAPHIC img188610151_0.jpg GRAPHIC 8131
11 GRAPHIC img188610151_1.jpg GRAPHIC 8702
12 GRAPHIC img189533672_0.jpg GRAPHIC 9163
13 GRAPHIC img189533672_1.jpg GRAPHIC 7875
14 GRAPHIC img189533672_2.jpg GRAPHIC 8702
15 GRAPHIC img190457193_0.jpg GRAPHIC 1600
16 GRAPHIC img190457193_1.jpg GRAPHIC 7875
  Complete submission text file 0000950170-24-033141.txt   3636888
Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Filer) CIK: 0001953530 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41636 | Film No.: 24761037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)